Pyxis Oncology
PYXS
PYXS
47 hedge funds and large institutions have $41.5M invested in Pyxis Oncology in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
28.3% less ownership
Funds ownership: 56.3% → 28% (-28%)
Holders
47
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.01M | |
| 2 | +$580K | |
| 3 | +$365K | |
| 4 |
Jane Street
New York
|
+$302K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$291K |
Top Sellers
| 1 | -$6.16M | |
| 2 | -$3.97M | |
| 3 | -$3.94M | |
| 4 |
Barclays
London,
United Kingdom
|
-$3.33M |
| 5 |
NM
Newtyn Management
New York
|
-$2.01M |